Some distinctions between flavin-containing and cytochrome P450 monooxygenases

Area of Science:

• Biochemistry
• Pharmacology
• Drug Metabolism

Background:

• Flavin-containing monooxygenases (FMOs) and cytochrome P450s (CYPs) are key enzyme families involved in xenobiotic metabolism.
• Understanding their distinct and shared characteristics is crucial for drug development and predicting drug toxicity.

Purpose of the Study:

• To summarize the differences and similarities between human FMOs and CYPs.
• To highlight the implications of these enzymes in drug metabolism, toxicity, and drug design.

Main Methods:

• Literature review of existing studies on FMO and CYP enzyme functions.
• Comparative analysis of reaction mechanisms, substrate specificities, and metabolic outcomes.
• Discussion of genetic variability and drug-drug interaction potential.

Main Results:

• FMOs primarily oxygenate soft nucleophiles, while CYPs catalyze C-H abstraction and oxidize N- and S-containing compounds.
• Both enzyme families convert lipophilic compounds to hydrophilic metabolites, but via distinct mechanisms.
• CYP-dependent oxidation is a major cause of observed clinical drug toxicity, unlike FMO-dependent pathways.
• Genetic variability exists for both FMO and CYP, contributing to inter-individual differences in drug metabolism.

Conclusions:

• FMOs are not readily induced or inhibited, suggesting fewer adverse drug-drug interactions compared to CYPs.
• The unique properties of FMOs present opportunities for improved drug design by incorporating FMO-mediated detoxification pathways.
• Developing drugs that utilize FMO pathways could lead to more predictable and safer drug-like molecules.